Pulse Biosciences, Inc.PLSENASDAQ
Loading
Debt to Equity Over TimeElevated
Percentile Rank64
5Y CAGR-28.4%
Studio
Year-over-Year Change

Debt-to-equity ratio

5Y CAGR
-28.4%/yr
Long-term compound
Percentile
P64
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthElevated
PeriodValueYoY Change
20250.09+20.5%
20240.08-62.4%
20230.21+100.6%
2022-33.79-10819.3%
20210.32-36.5%
20200.50+126.9%
20190.22-
20180.00-
20170.00-
20160.00-